From: Pharmacokinetic comparability of Prolastin®-C to Prolastin® in alpha1-antitrypsin deficiency: a randomized study
Geometric least squares mean ratio: Prolastin-C versus Prolastin
Potency assay
Content assay
Point estimate
90% CI
AUC 0-7 days , mg*h/mL
1.03
0.97-1.09
0.98
0.95-1.02